首页> 美国卫生研究院文献>Molecules >X-ray Structures of Precursors of Styrylpyridine-Derivatives Used to Obtain 4-((E)-2-(Pyridin-2-yl)vinyl)benzamido-TEMPO: Synthesis and Characterization
【2h】

X-ray Structures of Precursors of Styrylpyridine-Derivatives Used to Obtain 4-((E)-2-(Pyridin-2-yl)vinyl)benzamido-TEMPO: Synthesis and Characterization

机译:用于获得4-((E)-2-(吡啶-2-基)乙烯基)苯甲酰胺基-TEMPO的苯乙烯基吡啶衍生物的前体的X射线结构:合成与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synthesis and characterization of the precursor isomers trans-4-(2-(pyridin-2-yl)vinylbenzaldehyde (>I), trans-4-(2-(pyridin-4-yl)vinylbenzaldehyde (>II), trans-4-(2-(pyridin-2-yl)vinylbenzoic acid (>III) and (E)-4-(2-(pydridin-4-yl)vinylbenzoic acid (>IV) are reported. These compounds were prepared in order to obtain trans-4-((E)-2-(pyridin-2-yl)vinyl)benzamide-TEMPO (>V). Compounds >I and >II were obtained by using a Knoevenagel reaction in the absence of a condensing agent and solvent. Oxidation of the aldehyde group using the Jones reagent afforded the corresponding acid forms >III and >IV. A condensation reaction with 4-amino-TEMPO using oxalyl chloride/DMF/CH2Cl2 provided the 4-((E)-2-(pyridin-2-yl)vinyl)benzamide-TEMPO. Single crystals of compounds >I, >II and >III were obtained and characterized by X-ray diffraction. Compound >I belongs to space group P21/c, a = 12.6674(19) Å, b = 7.2173(11) Å, c = 11.5877(14) Å, β = 97.203(13)° and the asymmetric unit was Z = 4, whereas compound >II was in the space group P21, with a = 3.85728(9) Å, b = 10.62375(19) Å, c = 12.8625(2) Å, β = 91.722 (2)° and the asymmetric unit was Z = 2. Compound >III crystallized as single colorless needle crystals, belonging to the monoclinic system with space group P21, with Z = 2, with a = 3.89359(7) Å, b = 17.7014(3) Å, c = 8.04530(12) Å, β = 94.4030 (16)°. All compounds were completely characterized by IR, 1H-NMR, EI-MS and UV-Vis.
机译:前体异构体反式-4-(2-(吡啶-2-基)乙烯基苯甲醛(> I ),反式-4-(2-(吡啶-4-基)乙烯基苯甲醛( > II ),反式4-(2-(吡啶-2-基)乙烯基苯甲酸(> III )和(E)-4-(2-(pyriddin-4报道了-基)乙烯基苯甲酸(> IV ),制备这些化合物是为了获得反式-4-((E)-2-(吡啶-2-基)乙烯基)苯甲酰胺-TEMPO( > V )。在不存在缩合剂和溶剂的情况下,通过Knoevenagel反应获得化合物> I 和> II 。用Jones试剂得到相应的酸形式> III 和> IV 。使用草酰氯/ DMF / CH2Cl2与4-氨基-TEMPO进行缩合反应得到4-((E )-2-(吡啶-2-基)乙烯基)苯甲酰胺-TEMPO。得到化合物> I ,> II 和> III 的单晶,茶通过X射线衍射实现。化合物> I 属于空间群P21 / c,a = 12.6674(19)Å,b = 7.2173(11)Å,c = 11.5877(14)Å,β= 97.203(13)°,不对称单位为Z = 4,而化合物> II 在空间组P21中,a = 3.85728(9)Å,b = 10.62375(19)Å, c = 12.8625(2)Å,β = 91.722(2)°,不对称单位为 Z =2。化合物> III 结晶为单个无色针状晶体,属于单斜晶系,空间组为 P 21, Z = 2, a = 3.89359(7)Å, b = 17.7014(3)Å, c = 8.04530(12)Å,β = 94.4030(16)°。所有化合物均通过IR, 1 H-NMR,EI-MS和UV-Vis完全表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号